Skip to content
Menu

NRx Pharmaceuticals, Inc. NRXP

Full chart Compare
Set alert

Price alert · NRXP

All alert types
2.80 USD +0.35 (+14.29%)

Regular-session close

2.89 +0.09 +3.21%

After hours · Nov 18, 7:49 PM ET

2.46 Day range 2.91
1.62 52-week range 5.06
YTD
+3.32%
1 year
+22.81%

Discussion (134)

dlee413 NRXP 5 years ago #61

Matt -- lots of news here don't know fingerpicker. --- surprised he hasn't jumped back in--/. We're closer to what we knew all along. Good mr workman... I'm sure your smiling

dlee413 NRXP 5 years ago #63

I'm not buying but been holding for about 100 days. My hands are weary But I have no choice but to wait it out .. I've been around since fingerpicker, John Jones , and good old mr workman.. mr workman has been faithful. I guess John Jones lost a couple million and bailed ... haven't heard from him in a while .... sad... thing is we have a drug that works... so despite your view on management .. your view is speculative.. the drug in fact works... so my hope is fda approved for that level Alone and approves rather sooner than later

dlee413 NRXP 5 years ago #64

Guys. I've been here since July. This is a speculative stock investment and all any of you talk about is speculation... im here for eua and other pipeline drugs ---I speculate will bring price $40+ Why would you day trade this stock. Much better options to penny flip.

dlee413 NRXP 5 years ago #66

Murrow_09---- thanks for sharing that post. Still believing in JJ. Been bag holding since July. -- for all the old holders... John Jones has more invested in this than any single holder, less of the private placement I know of... would love to hear your thoughts John--- I'm hoping for the good news just like everyone else.

Ogma NRXP 5 years ago #67

There it is.

Ellie Menkaure NRXP 5 years ago #69

RESULTS please stop posting misinformation. You obviously don’t know how journal publications go ESPECIALLY when it is in pre-print. The authors of the article are Principal Investigators of the trial that work at different clinics (which recruited the patients for the trials. They are not employees of $NRXP. Yes, they have to include JJ as an author but that doesn’t mean he had read the article especially since it hasn’t been submitted for publication. Stop spreading conspiracy theories as to why there was a typo months ago announcing approval in a DRAFT of an article written by a bunch of PIs.

Sign in to join the discussion